235 related articles for article (PubMed ID: 35130114)
1. Circulating microbiome in patients with portal hypertension.
Gedgaudas R; Bajaj JS; Skieceviciene J; Varkalaite G; Jurkeviciute G; Gelman S; Valantiene I; Zykus R; Pranculis A; Bang C; Franke A; Schramm C; Kupcinskas J
Gut Microbes; 2022; 14(1):2029674. PubMed ID: 35130114
[TBL] [Abstract][Full Text] [Related]
2. No difference in portal and hepatic venous bacterial DNA in patients with cirrhosis undergoing transjugular intrahepatic portosystemic shunt insertion.
Mortensen C; Karlsen S; Grønbæk H; Nielsen DT; Frevert S; Clemmesen JO; Møller S; Jensen JS; Bendtsen F
Liver Int; 2013 Oct; 33(9):1309-15. PubMed ID: 23763259
[TBL] [Abstract][Full Text] [Related]
3. Rifaximin has minor effects on bacterial composition, inflammation, and bacterial translocation in cirrhosis: A randomized trial.
Kimer N; Pedersen JS; Tavenier J; Christensen JE; Busk TM; Hobolth L; Krag A; Al-Soud WA; Mortensen MS; Sørensen SJ; Møller S; Bendtsen F;
J Gastroenterol Hepatol; 2018 Jan; 33(1):307-314. PubMed ID: 28671712
[TBL] [Abstract][Full Text] [Related]
4. Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg.
Arab JP; Martin-Mateos RM; Shah VH
Hepatol Int; 2018 Feb; 12(Suppl 1):24-33. PubMed ID: 28550391
[TBL] [Abstract][Full Text] [Related]
5. FXR modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis.
Sorribas M; Jakob MO; Yilmaz B; Li H; Stutz D; Noser Y; de Gottardi A; Moghadamrad S; Hassan M; Albillos A; Francés R; Juanola O; Spadoni I; Rescigno M; Wiest R
J Hepatol; 2019 Dec; 71(6):1126-1140. PubMed ID: 31295531
[TBL] [Abstract][Full Text] [Related]
6. Improvement of gut microbiome and intestinal permeability following splenectomy plus pericardial devascularization in hepatitis B virus-related cirrhotic portal hypertension.
Zhao Y; Zhou R; Guo Y; Chen X; Zhang A; Wang J; Ji F; Qin B; Geng J; Kong G; Li Z
Front Immunol; 2022; 13():941830. PubMed ID: 36159870
[TBL] [Abstract][Full Text] [Related]
7. Plasma Nogo-A and placental growth factor levels are associated with portal hypertension in patients with liver cirrhosis.
Gelman S; Salteniene V; Pranculis A; Skieceviciene J; Zykus R; Petrauskas D; Kupcinskas L; Canbay A; Link A; Kupcinskas J
World J Gastroenterol; 2019 Jun; 25(23):2935-2946. PubMed ID: 31249451
[TBL] [Abstract][Full Text] [Related]
8. Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity.
Mandorfer M; Schwabl P; Paternostro R; Pomej K; Bauer D; Thaler J; Ay C; Quehenberger P; Fritzer-Szekeres M; Peck-Radosavljevic M; Trauner M; Reiberger T; Ferlitsch A;
Aliment Pharmacol Ther; 2018 Apr; 47(7):980-988. PubMed ID: 29377193
[TBL] [Abstract][Full Text] [Related]
9. Circulating levels of butyrate are inversely related to portal hypertension, endotoxemia, and systemic inflammation in patients with cirrhosis.
Juanola O; Ferrusquía-Acosta J; García-Villalba R; Zapater P; Magaz M; Marín A; Olivas P; Baiges A; Bellot P; Turon F; Hernández-Gea V; González-Navajas JM; Tomás-Barberán FA; García-Pagán JC; Francés R
FASEB J; 2019 Oct; 33(10):11595-11605. PubMed ID: 31345057
[TBL] [Abstract][Full Text] [Related]
10. Microbiome and bacterial translocation in cirrhosis.
Gómez-Hurtado I; Such J; Francés R
Gastroenterol Hepatol; 2016 Dec; 39(10):687-696. PubMed ID: 26775042
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the circulating microbiome in acute-on-chronic liver failure associated with hepatitis B.
Zhang Y; Zhao R; Shi D; Sun S; Ren H; Zhao H; Wu W; Jin L; Sheng J; Shi Y
Liver Int; 2019 Jul; 39(7):1207-1216. PubMed ID: 30864226
[TBL] [Abstract][Full Text] [Related]
12. Exploratory Research on the Relationship between Human Gut Microbiota and Portal Hypertension.
Yokoyama K; Tsuchiya N; Yamauchi R; Miyayama T; Uchida Y; Shibata K; Fukuda H; Umeda K; Takata K; Tanaka T; Inomata S; Morihara D; Takeyama Y; Shakado S; Sakisaka S; Hirai F
Intern Med; 2020; 59(17):2089-2094. PubMed ID: 32879200
[TBL] [Abstract][Full Text] [Related]
13. Gut-liver axis signaling in portal hypertension.
Simbrunner B; Mandorfer M; Trauner M; Reiberger T
World J Gastroenterol; 2019 Oct; 25(39):5897-5917. PubMed ID: 31660028
[TBL] [Abstract][Full Text] [Related]
14. TIMP-1 in patients with cirrhosis: relation to liver dysfunction, portal hypertension, and hemodynamic changes.
Busk TM; Bendtsen F; Nielsen HJ; Jensen V; Brünner N; Møller S
Scand J Gastroenterol; 2014 Sep; 49(9):1103-10. PubMed ID: 25048331
[TBL] [Abstract][Full Text] [Related]
15. Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension.
Garcia-Tsao G; Bosch J; Kayali Z; Harrison SA; Abdelmalek MF; Lawitz E; Satapathy SK; Ghabril M; Shiffman ML; Younes ZH; Thuluvath PJ; Berzigotti A; Albillos A; Robinson JM; Hagerty DT; Chan JL; Sanyal AJ;
J Hepatol; 2020 May; 72(5):885-895. PubMed ID: 31870950
[TBL] [Abstract][Full Text] [Related]
16. A different gut microbiome linked to inflammation found in cirrhotic patients with and without hepatocellular carcinoma.
Piñero F; Vazquez M; Baré P; Rohr C; Mendizabal M; Sciara M; Alonso C; Fay F; Silva M
Ann Hepatol; 2019; 18(3):480-487. PubMed ID: 31023615
[TBL] [Abstract][Full Text] [Related]
17. Microbial Profiles of Cirrhosis in the Human Small Intestine.
Dong TS; Jacobs JP; Hussain SK
Curr Gastroenterol Rep; 2019 Aug; 21(10):50. PubMed ID: 31444636
[TBL] [Abstract][Full Text] [Related]
18. Infection as a Trigger for Portal Hypertension.
Steib CJ; Schewe J; Gerbes AL
Dig Dis; 2015; 33(4):570-6. PubMed ID: 26159275
[TBL] [Abstract][Full Text] [Related]
19. Distinct Gut Microbial Signature and Host Genetic Variants in Association with Liver Fibrosis Severity in Patients with MASLD.
Satthawiwat N; Jinato T; Sutheeworapong S; Tanpowpong N; Chuaypen N; Tangkijvanich P
Nutrients; 2024 Jun; 16(12):. PubMed ID: 38931155
[TBL] [Abstract][Full Text] [Related]
20. Markers of immunity and bacterial translocation in cirrhosis.
Mortensen C
Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
